M. Van-den-akker-van-marle, J. Bruil, and S. Detmar, Evaluation of cost of disease: Assessing the burden to society of asthma in children in the European Union, Allergy, vol.156, issue.Suppl., pp.140-149, 2005.
DOI : 10.1164/ajrccm.156.3.9611072

, Asthme de l'enfant de moins de 36 mois : diagnostic, prise en charge et traitement en dehors des épisodes aigus. Synthèse des recommandations professionnelles, HAS, 2009.

S. Suissa, P. Ernst, and A. Kezouh, Regular use of inhaled corticosteroids and the long term prevention of hospitalisation for asthma, Thorax, vol.57, issue.10, pp.880-884, 2002.
DOI : 10.1136/thorax.57.10.880

N. Barnes and C. Miller, Effect of leukotriene receptor antagonist therapy on the risk of asthma exacerbations in patients with mild to moderate asthma: an integrated analysis of zafirlukast trials, Thorax, vol.55, issue.6, pp.478-83, 2000.
DOI : 10.1136/thorax.55.6.478

, The Childhood Asthma Management Program Research Group. Long-term effects of budesonide or nedocromil in children with asthma, N Engl J Med, vol.343, pp.1054-63, 2000.

G. Garcia, M. Wahn, U. Gilles, L. Swern, A. Tozzi et al., Montelukast, Compared With Fluticasone, for Control of Asthma Among 6- to 14-Year-Old Patients With Mild Asthma: The MOSAIC Study, PEDIATRICS, vol.116, issue.2, pp.360-369, 2005.
DOI : 10.1542/peds.2004-1172

, Global Initiative for Asthma (GINA) Global strategy for asthma management and prevention, 2014.

T. British, S. Society, and . Network, British guidelines on the management of asthma -A national clinical guideline, 2011.

, Guidelines for the Diagnosis and Management of Asthma, Expert Panel. Report, vol.3, 2007.

M. Lougheed, C. Lemiere, S. Dell, F. Ducharme, J. Fitzgerald et al., Canadian thoracic society asthma management continuum -consensus summary for children six years of age and over, and adults, Can Respir J, issue.17, pp.201015-201039, 2010.

S. Szefler, B. Phillips, F. Martinez, V. Chinchilli, R. Lemanske et al., Characterization of within-subject responses to fluticasone and montelukast in childhood asthma, Journal of Allergy and Clinical Immunology, vol.115, issue.2, pp.233-275, 2005.
DOI : 10.1016/j.jaci.2004.11.014

M. Dorais, L. Blais, and I. Chabot, Treatment Persistence with Leukotriene Receptor Antagonists and Inhaled Corticosteroids, Journal of Asthma, vol.42, issue.5, pp.385-93, 2005.
DOI : 10.1081/JAS-200063007

D. Bukstein, A. Luskin, and A. Bernstein, ???Real-world??? effectiveness of daily controller medicine in children with mild persistent asthma, Annals of Allergy, Asthma & Immunology, vol.90, issue.5, pp.543-552, 2003.
DOI : 10.1016/S1081-1206(10)61848-0

P. Tuppin, W. De-roquefeuil, P. Ricordeau, and Y. Merlière, French national health insurance information system and the permanent beneficiaries sample, Revue d'??pid??miologie et de Sant?? Publique, vol.58, issue.4, pp.286-90, 2010.
DOI : 10.1016/j.respe.2010.04.005

L. Blais, F. Kettani, C. Lemière, M. Beauchesne, S. Perreault et al., Inhaled corticosteroids vs. leukotriene-receptor antagonists and asthma exacerbations in children, Respiratory Medicine, vol.105, issue.6, pp.846-55, 2011.
DOI : 10.1016/j.rmed.2010.12.007

M. Herr, L. Nikasinovic, C. B. Momas, I. Just, and J. , ??pid??miologie des allergies respiratoires chez le nourrisson, Revue des Maladies Respiratoires, vol.24, issue.10, pp.1314-1342, 2007.
DOI : 10.1016/S0761-8425(07)78509-1

A. Afrite, C. Allonier, L. Com-ruelle, L. Guen, and N. L-'asthme-en-france-en, , pp.1-8, 2006.

, French Health Insurance http://www.ameli.fr/l-assurance-maladie/statistiques-et- publications/donnees-statistiques/medicament/medic-am, 2008.

P. Godard, D. Blic, J. Huas, D. Boucot, I. Pribil et al., ER???ASTHME : ??valuation du contr??le de l???asthme chez 1 410 enfants de 6 ?? 14 ans en m??decine g??n??rale, Revue des Maladies Respiratoires, vol.23, issue.HS1, pp.8-12, 2006.
DOI : 10.1016/S0761-8425(06)72100-3

D. Blic, J. Boucot, I. Pribil, C. Huas, D. Godard et al., Niveau de??contr??le de??l'asthme chez??l'enfant en??m??decine g??n??rale en??France: r??sultats de??l'??tude ER'ASTHME, Archives de P??diatrie, vol.14, issue.9, pp.1069-75, 2007.
DOI : 10.1016/j.arcped.2007.05.001

D. Price, A. Chisholm, T. Van-der-molen, N. Roche, V. Hillyer et al., Reassessing the Evidence Hierarchy in Asthma: Evaluating Comparative Effectiveness, Current Allergy and Asthma Reports, vol.65, issue.Suppl 1, pp.526-564, 2011.
DOI : 10.1111/j.1398-9995.2010.02439.x

J. Krishnan, M. Schatz, and A. Apter, A call for action: Comparative effectiveness research in asthma, Journal of Allergy and Clinical Immunology, vol.127, issue.1, pp.123-130, 2011.
DOI : 10.1016/j.jaci.2010.08.032

K. Martin-latry and B. Bégaud, Pharmacoepidemiological research using French reimbursement databases: yes we can! Pharmacoepidemiol Drug Sa, pp.256-65, 2010.

H. Reddel, D. Taylor, E. Bateman, L. Boulet, H. Boushey et al., An Official American Thoracic Society/European Respiratory Society Statement: Asthma Control and Exacerbations, American Journal of Respiratory and Critical Care Medicine, vol.180, issue.1, pp.59-99, 2009.
DOI : 10.1046/j.1472-9725.2001.00007.x

B. Strom, Methodologic Challenges to Studying Patient Safety and Comparative Effectiveness, Medical Care, vol.45, issue.Suppl 2, pp.13-18, 2007.
DOI : 10.1097/MLR.0b013e318041f752

, Submit your next manuscript to BioMed Central and take full advantage of

, ? Convenient online submission ? Thorough peer review ? No space constraints or color figure charges ? Immediate publication on acceptance ? Inclusion in PubMed, CAS, Scopus and Google Scholar ? Research which is freely available for redistribution Submit your manuscript at www